Grants from National Institutes of Health

12,798 opportunities — 401 currently open. Filter open grants →

First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)

Posted
Closes: Oct 15, 2027

Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)

Posted
Closes: Oct 15, 2027

Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)

Posted
Closes: Oct 15, 2027

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)

Posted
Closes: Oct 15, 2027

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

Posted
Closes: Oct 15, 2027

Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required)

Posted
Closes: Oct 15, 2027

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

Posted
Closes: Nov 17, 2026

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)

Posted
Closes: Jan 7, 2027

New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)

Posted
Closes: May 7, 2027

New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)

Posted
Closes: May 7, 2027

The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)

Posted
Closes: Jan 7, 2028

Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R01 Clinical Trial Required)

Posted
Closes: Jan 7, 2028

Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R34 Clinical Trial Required)

Posted
Closes: Jan 7, 2028

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

Posted
Closes: Dec 23, 2027

Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)

Posted
Closes: Dec 23, 2027

Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)

Posted
Closes: Dec 23, 2027

Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)

Posted
Closes: Dec 23, 2027

Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)

Posted
Closes: Jan 7, 2028

Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)

Posted
Closes: Jan 7, 2028

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

Posted
Closes: Nov 19, 2026